Ribociclib 200mg tablets
NHS hospitals in England used £130,238,858 of indicative cost of Ribociclib 200mg tablets in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is up 62.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ribociclib 200mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ribociclib 200mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £5,598,119 |
| The Royal Marsden Nhs Foundation Trust | £4,841,947 |
| The Christie Nhs Foundation Trust | £4,514,641 |
| Western Sussex Hospitals Nhs Found Trust | £4,157,875 |
| Barts Health Nhs Trust | £3,472,480 |
| Colchester Hospital University Nhs Ft | £2,947,967 |
| East And North Hertfordshire Nhs Trust | £2,852,372 |
| Sheffield Teaching Hospitals Nhs Trust | £2,638,764 |
| Imperial College Healthcare Nhs Trust | £2,638,288 |
| Royal Devon & Exeter Nhs Foundation Trst | £2,488,820 |
The primary-care picture
Ribociclib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ribociclib medicine page.